Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD
This specialty pharma firm focused on pain management therapies reported a notable insider sale amid steady revenue and recent stock gains.
Source: www.fool.com
This specialty pharma firm focused on pain management therapies reported a notable insider sale amid steady revenue and recent stock gains.